Position in EPRX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,551,188
+$458,310 QoQ
Shares Held
234,673
+55.5% QoQ
Ownership
0.355%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 68 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CIBC WORLD MARKET INC. holds $65,253,987 across 30 Biotechnology names. EPRX ranks #9 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GMAB |
Genmab A/S
|
514,764 | $14,140,567 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
27,626 | $13,722,662 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
21,806 | $13,596,913 | |
| 4 | RPRX |
Royalty Pharma plc
|
82,547 | $4,628,410 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
14,093 | $2,639,337 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
7,221 | $2,173,737 | |
| 7 | DYN |
Dyne Therapeutics, Inc.
|
75,783 | $1,683,140 | |
| 8 | ASND |
Ascendis Pharma A/S
|
6,156 | $1,641,928 |
All Filings in EPRX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,551,188 | 234,673 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,092,878 | 150,950 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $438,277 | 58,050 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $88,500 | 15,000 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $86,400 | 15,000 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||